newsfilter
← Latest News
PR Newswire·

U.S. District Court Upholds Validity of CINVANTI® Patents

Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the U.S. District...